Last reviewed · How we verify
Telmisartan plus Captopril
Telmisartan plus Captopril is a Small molecule drug developed by Coordinación de Investigación en Salud, Mexico. It is currently FDA-approved. Also known as: Capotena, Micardis.
Telmisartan is a small molecule that acts as a Type-1 angiotensin II receptor antagonist. It is used to treat hypertension and has been studied in various clinical trials for other conditions, including COVID-19, but its exact indications and effects are not specified in the provided facts.
At a glance
| Generic name | Telmisartan plus Captopril |
|---|---|
| Also known as | Capotena, Micardis |
| Sponsor | Coordinación de Investigación en Salud, Mexico |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (PHASE3)
- ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
- Coronavirus (COVID-19) ACEi/ARB Investigation (PHASE4)
- Use of Telmisartan and Captopril in Inflammation of Hemodialysis Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Telmisartan plus Captopril CI brief — competitive landscape report
- Telmisartan plus Captopril updates RSS · CI watch RSS
- Coordinación de Investigación en Salud, Mexico portfolio CI
Frequently asked questions about Telmisartan plus Captopril
What is Telmisartan plus Captopril?
Who makes Telmisartan plus Captopril?
Is Telmisartan plus Captopril also known as anything else?
What development phase is Telmisartan plus Captopril in?
Related
- Manufacturer: Coordinación de Investigación en Salud, Mexico — full pipeline
- Also known as: Capotena, Micardis
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing